Omada Health, Inc. $OMDA Stock Holdings Lifted by Walleye Capital LLC

Walleye Capital LLC increased its holdings in Omada Health, Inc. (NASDAQ:OMDA) by 677.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 352,443 shares of the company’s stock after buying an additional 307,097 shares during the period. Walleye Capital LLC’s holdings in Omada Health were worth $4,430,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP acquired a new stake in Omada Health during the fourth quarter worth about $29,000. TD Waterhouse Canada Inc. acquired a new position in Omada Health in the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. bought a new position in shares of Omada Health during the second quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new stake in shares of Omada Health during the 4th quarter worth approximately $45,000. Finally, Strs Ohio raised its position in shares of Omada Health by 151.0% during the 4th quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after purchasing an additional 2,567 shares during the period.

Analysts Set New Price Targets

A number of research firms recently issued reports on OMDA. Evercore restated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Citizens Jmp increased their target price on Omada Health from $21.00 to $27.00 and gave the stock a “market outperform” rating in a research report on Monday. Wells Fargo & Company raised their target price on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday, May 8th. BTIG Research began coverage on shares of Omada Health in a report on Friday, July 17th. They set a “buy” rating and a $30.00 price target for the company. Finally, Morgan Stanley reissued an “overweight” rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $24.33.

Omada Health Trading Down 5.0%

Shares of NASDAQ:OMDA opened at $21.84 on Thursday. The firm’s 50 day moving average is $19.47 and its two-hundred day moving average is $15.81. The firm has a market capitalization of $1.30 billion and a P/E ratio of -80.89. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The business had revenue of $78.05 million during the quarter. Analysts predict that Omada Health, Inc. will post -0.01 EPS for the current year.

Insider Buying and Selling at Omada Health

In other Omada Health news, CAO Craig Gracey sold 2,083 shares of the business’s stock in a transaction on Monday, June 29th. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00. Following the completion of the transaction, the chief accounting officer owned 858 shares in the company, valued at approximately $18,018. The trade was a 70.83% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Sean P. Duffy sold 25,886 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total value of $587,094.48. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at approximately $9,341,007.48. The trade was a 5.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 193,462 shares of company stock valued at $3,927,425 in the last quarter. Corporate insiders own 6.38% of the company’s stock.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.